Impossible Foods Donates Its Millionth Burger and Doubles Down on Social Good For 2021 REDWOOD CITY, Calif. (Business Wire) Impossible Foods donated its millionth Impossible Burger this week, achieving the startup’s ambitious 2020 goal to nourish communities in need during COVID-19.
Alameda County Community Food Bank, a long-standing Impossible Foods’ partner, was the recipient of the 1 millionth Impossible Burger. The organization distributes millions of healthy meals every year, and is on the forefront of new approaches to ending hunger and poverty. Impossible Foods’ Social Good program has also collaborated with social impact groups such as Colin Kaepernick’s Know Your Rights Camp, Isaac Rochell’s Local Human, Black Lives Matter of Greater New York, Rethink Food and SodexoMAGIC, the nation’s leading dining service provider chaired by NBA legend Earvin “Magic” Johnson.
From Oxford of the East to a Growing Startup Hub
Rachita Sharma, Editor, StartupCityNestled at the foot of ShayadriMountains is Pune, an old historical city with a bright youthful spirit. The second largest city in the state of Maharashtra, for years Pune was largely recognized as a city of culture and art. Home to various educational institutions of repute, the city was christened the ‘Oxford of the East’. However, the city lagged behind when it came to being a financially forward market. But the young and restless demographic of the city is keen to change that and is striving to turn the city into the next startup hub of India.
Conductor Raises an Additional $20 Million from Temasek, Expanding Latest Fundraising Round to $170 Million
Conductor Raises an Additional $20 Million from Temasek, Expanding Latest Fundraising Round to $170 Million Conductor, the leading card issuing and banking-as-a-service software platform in Latin America, announced today it has raised an additional $20 million from Temasek, a global investment company headquartered in Singapore. This new investment adds to Conductors latest round of fundraising, increasing it to a total $170 million. Antonio Soares, CEO of Conductor, remarked, We are thrilled to have built such a strong and unique investor base. The caliber of the investors that have joined our journey reflects the quality of our business and demonstrates that we are on the right path. We are very happy to be adding Temasek to this select group. This round enables us to continue moving firmly and aggressively towards our vision of delivering the future of digital commerce
IndiGo Takes to the Cloud With Druva
Wednesday, December 16, 2020 1:07PM IST (7:37AM GMT)
With Druva Cloud Platform, India’s largest passenger airline protects thousands of devices, reduces cost and ensures business continuity
Sunnyvale, Calif., United States:
Druva Inc., the Leader in Cloud Data Protection and Management, today announced that it has helped IndiGo slash IT support calls by 90 percent and secure thousands of devices through a migration to cloud data protection. As India’s largest passenger airline, Druva’s SaaS-based data management technology offered the company a single solution for protecting its sensitive aviation data and a robust disaster recovery approach to ensure minimal impact to business operations. With features such as immediate access to all backups, powerful data governance capabilities and fast search to restore data, IndiGo’s IT team is now able to focus on enhancing end-
AbCellera officially closes initial public offering with $555.5 million gross proceeds
Vancouver biotech company AbCellera Biologics has officially announced the close of its initial public offering (IPO) on the Nasdaq, pulling in gross proceeds of $555.5 million.
The amount includes the company’s underwriters exercising in full their option to purchase 3.6 million additional common shares at $20 (all numbers in USD). The gross proceeds is the final total before deducting underwriting discounts and commissions and estimated offering expenses.
AbCellera has developed a drug discovery platform that searches and analyzes immune systems to find antibodies.
AbCellera began trading on the Nasdaq Friday morning (under the symbol ‘ABCL’), with great initial success. Within minutes of listing the biotech’s stock tripled in value from the $20 per share that it had priced its IPO at. By the afternoon AbCellera’s shares were trading higher than $70.